Parkinson’s disease adds measurable risk after elective hip replacement
Elective total hip arthroplasty is meant to restore mobility, reduce pain, and speed return to function. In patients with Parkinson’s disease, those goals collide with a neurologic disorder that alters gait, posture, muscle tone, balance, and postural reflexes. A national analysis in the Nationwide Readmissions Database now shows that the perioperative penalty is real: patients with Parkinson’s disease faced more index-hospital complications and substantially more 90-day readmission, reoperation, and revision after primary THA.
The pattern is clinically familiar even before the numbers are unpacked. Parkinsonian rigidity and impaired protective responses raise the chance of instability around a new prosthetic joint, while frailty and comorbidity burden can amplify respiratory, urinary, and hematologic complications in the immediate postoperative period.
National matched data capture a higher-risk arthroplasty population
Investigators used the Nationwide Readmissions Database from 2020 through 2022 and identified adults who underwent elective primary THA on hospital day 0. They then built a variable-ratio propensity score-matched cohort of up to 1:5, comparing patients with Parkinson’s disease against controls. Matching incorporated demographics, payer status, hospital characteristics, calendar year, and comorbidities, and balance was strong across groups, with all standardized mean differences below 0.1.
The final matched cohort included 12,143 elective primary THAs, of which 2,043 were performed in patients with Parkinson’s disease and 10,100 in controls. The design matters because it limits the obvious confounding that often clouds claims-based surgery studies. Even after that adjustment, the signal remained clear.
Complications clustered around frailty, instability, and infection
During the index hospitalization, patients with Parkinson’s disease experienced higher rates of blood transfusion, pneumonia, urinary tract infection, and hip dislocation, with all comparisons reaching statistical significance at p ≤ 0.015. In-hospital mortality stayed low and did not differ meaningfully between groups.
Those findings fit the biology of Parkinson’s disease rather than contradict it. Dysphagia, impaired cough, reduced mobility, and slower recovery from anesthesia can all contribute to pulmonary complications. Urinary dysfunction is common in Parkinson’s disease and can complicate the postoperative course. Hip dislocation is particularly intuitive: abnormal tone, bradykinesia, postural instability, and difficulty adhering to movement restrictions can threaten early prosthetic stability.
Length of stay was longer in the Parkinson’s group, yet hospital charges did not differ significantly. In practical terms, the price of the admission did not necessarily rise, but the clinical cost did: more complications, more monitoring, and more downstream utilization.
Ninety-day utilization rose sharply after discharge
The postdischarge period carried the most consequential divergence. Within 90 days, readmission occurred in 10.3% of patients with Parkinson’s disease versus 5.8% of controls, translating to an odds ratio of 1.86 with p < 0.001. Procedural escalation also increased substantially. Reoperation occurred in 3.3% versus 0.9%, and revision occurred in 3.0% versus 0.7%, again with p < 0.001 for both comparisons.
Those are not small differences. A doubled readmission rate after an elective orthopedic procedure points to a population that leaves the hospital vulnerable, not merely a cohort with more incidental follow-up. The rise in revision and reoperation suggests that some early setbacks were not medically managed alone; they crossed into procedural failure, most likely driven by instability, complications, or both.
For surgeons and perioperative teams, the message is straightforward. Parkinson’s disease should be treated as a marker of elevated early post-THA risk, not as a background diagnosis that can be parked in the chart while the joint replacement proceeds on a standard pathway. A patient may survive the operation without excess mortality and still pay a steep postoperative price in infection workup, rehabilitation delays, redislocation risk, and return to the operating room.
Why the postoperative window matters so much in Parkinson’s disease
THA success depends on more than implant selection and technical execution. It depends on the patient’s ability to mobilize safely, protect the joint, engage in rehabilitation, and tolerate the cascade of physiologic stressors that follow major surgery. Parkinson’s disease interrupts each of those steps. Motor fluctuations, impaired balance, autonomic dysfunction, and reduced reserve can all undermine the early recovery phase, when the prosthesis is most exposed to mechanical stress and the patient is most dependent on coordinated care.
The early complication profile in this study also argues for closer inpatient vigilance. Pneumonia and urinary tract infection can slow mobilization, extend hospitalization, and compound weakness. Blood transfusion may reflect greater perioperative vulnerability or a lower threshold for intervention in a frailer population. Hip dislocation, once it occurs, can trigger a sequence of emergency care, repeat procedures, and loss of functional momentum that is difficult to reverse.
Perioperative planning needs to match the neurologic diagnosis
The findings point toward a more deliberate surgical pathway for patients with Parkinson’s disease undergoing elective THA. Preoperative optimization should account for mobility limitations, medication timing, fall risk, pulmonary status, and the likelihood of extended postoperative support. Discharge planning should anticipate a higher chance of early reassessment rather than assuming routine recovery.
Enhanced surveillance after discharge may be the most actionable consequence of the study. Early follow-up, rehab coordination, medication reconciliation, and rapid evaluation of wound, respiratory, urinary, or mechanical symptoms could help intercept problems before they escalate to readmission or revision. The study does not provide a protocol for reducing risk, but it does define the population that most clearly needs one.
The dataset also has the strengths and limits typical of national administrative work. It is large enough to detect uncommon but important outcomes, and the matching strategy was robust. It cannot, however, capture granular neurologic severity, surgical technique, implant choice, rehabilitation adherence, or the exact reasons behind every readmission and reoperation. Even so, the direction of effect is too consistent to ignore: Parkinson’s disease was linked to more perioperative complications and a distinctly more fragile 90-day course after elective primary THA.